HansBiomed Balance Sheet Health
Financial Health criteria checks 6/6
HansBiomed has a total shareholder equity of ₩74.1B and total debt of ₩31.3B, which brings its debt-to-equity ratio to 42.2%. Its total assets and total liabilities are ₩125.0B and ₩50.8B respectively.
Key information
42.2%
Debt to equity ratio
₩31.30b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩8.02b |
| Equity | ₩74.14b |
| Total liabilities | ₩50.82b |
| Total assets | ₩124.96b |
Recent financial health updates
Is HansBiomed (KOSDAQ:042520) A Risky Investment?
Oct 29
Is HansBiomed (KOSDAQ:042520) A Risky Investment?
Feb 29Does HansBiomed (KOSDAQ:042520) Have A Healthy Balance Sheet?
Mar 06Recent updates
Is HansBiomed (KOSDAQ:042520) A Risky Investment?
Oct 29Is HansBiomed (KOSDAQ:042520) A Risky Investment?
Feb 29HansBiomed Corporation (KOSDAQ:042520) Shares Fly 25% But Investors Aren't Buying For Growth
Feb 29Are Dividend Investors Making A Mistake With HansBiomed Corporation (KOSDAQ:042520)?
Apr 10Does HansBiomed (KOSDAQ:042520) Have A Healthy Balance Sheet?
Mar 06HansBiomed's(KOSDAQ:042520) Share Price Is Down 63% Over The Past Three Years.
Jan 30Are HansBiomed's (KOSDAQ:042520) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Dec 08
Declining Stock and Decent Financials: Is The Market Wrong About HansBiomed Corporation (KOSDAQ:042520)?
Nov 20Financial Position Analysis
Short Term Liabilities: A042520's short term assets (₩50.5B) exceed its short term liabilities (₩45.9B).
Long Term Liabilities: A042520's short term assets (₩50.5B) exceed its long term liabilities (₩4.9B).
Debt to Equity History and Analysis
Debt Level: A042520's net debt to equity ratio (31.4%) is considered satisfactory.
Reducing Debt: A042520's debt to equity ratio has reduced from 43.7% to 42.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A042520 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: A042520 has sufficient cash runway for 2.2 years if free cash flow continues to reduce at historical rates of 10.8% each year.